AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Kontron AG (formerly S&T AG)

Investor Presentation May 6, 2021

802_ip_2021-05-06_5c0ce325-7304-48bd-9322-9298a07375fb.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

INVESTOR RELATIONS PRESENTATION

Hannes Niederhauser, CEO Richard Neuwirth, CFO

May 2021

HIGH- AND LOWLIGHTS 2021

HIGHLIGHTS LOWLIGHTS

  • › Q1/2021: Growth of 8.9% in revenues and 12.8% in EBITDA vs Q1/2020
  • › Q1/2021: EUR 8.7 Mio. in share buybacks (since 2019 EUR 38 Mio.)
  • › 30 cent record dividend for 2020
  • › Business model resilient to Covid-19-Pandemic
  • › Strong order intake in Q1/2021 of EUR 404 Mio.

  • › Chip shortage impact: EUR 10.5 Mio. of not delivered orders in Q1

  • › North America weak due to FX USD -9.3%, avionics and chip shortage
  • › 6.33% reported short positions (by 3/2021) but decreasing

KPI´S 2021 GOOD RESULTS IN ALL PARAMETERS

GROSS PROFIT

EBITDA

OPERATING CASH FLOW

(in EUR Mio.)

Q1 2021 was impacted by chip shortage and USD | We reiterate our FY 2021 guidance of min. EUR 1.4 Bn. @ min. EUR 140 Mio. EBITDA

S&T GROUP BALANCE SHEET

Mio
EUR
31/03/2021 31/12/2020 31/03/2021 31/12/2020
NON-CURRENT
ASSETS
506
1
506
0
CAPITAL
AND
RESERVES
412
8
409
5
Fixed
Assets
469
7
469
3
Equity 412
8
409
5
as of
, plant
and
Property
equipment
133
4
135
1
as of
shares
Treasury
-34
9
-26
2
as of
Goodwill
201
2
199
5
NON-CURRENT
LIABILITIES
386
5
353
8
Other
Assets
36
3
36
6
loans
borrowings
and
Long-term
251
3
218
8
CURRENT
ASSETS
740
8
740
7
Other
Liabilities
Non-Current
135
3
135
0
Inventories 171
1
159
9
CURRENT
LIABILITIES
447
5
483
4
Trade
receivables
183
3
204
5
Trade
payables
170
3
210
0
from
Contract
Assets
Customers
28
6
23
6
Liabilities
from
Contract
Customers
68
9
69
7
Cash
and
cash
equivalents
278
4
281
9
Short-term
loans
and
borrowings
60
1
42
8
Other
receivables
and
prepayments
79
4
70
9
Other
Liabilities
Current
148
3
160
9
Total
Assets
1
246
9
,
1
246
6
,
Total
Liabilities
&
Equity
1
246
9
,
1
246
6
,
Equity
Ratio
1%
33
8%
32
Cash/Net
Debt*
Net
-33
0
20
3
Working
Capital
excluding
15**
IFRS
184
1
154
3

Inventory build up to cover chip shortage| Factoring reduced due to high cash position by ~ EUR 21 Mio.

* Definition Net Cash: Cash and cash equivalents less non-current and current financing liabilities (excl. liabilities from leasing according to IFRS 16)

** Definition Working Capital: Inventories plus trade receivables less trade payables (excl. IFRS 15 contract assets and liabilities)

PEC PROGRAM IMPROVE CASH CONVERSION AND WORKING CAPITAL

OPERATING CASH FLOW (IN EUR MIO.) 26,7 61,4 44,9 35,5 83,4 140,8 100 120 140 2015 2016 2017 2018 2019 2020 -25.8 -13 6.4 -26.8 Q1-18 Q1-19 Q1-21 Q1-20

(IN EUR MIO.) KPI DEVELOPMENT
in
EUR Mio.
2018 2019 2020 Q1-2021
Revenue 990 1,123 1,255 294
Inventory 74 days
(131 Mio.)
73 days
(147 Mio.)
68 days
(160 Mio.)
94 days
(171 Mio.)
A/R 75 days
(202 Mio.)
69 days
(212
Mio.)
59 days
(205 Mio.)
57 days
(183 Mio.)
Factoring 56 Mio. (20%) 63 Mio. (23%) 77 Mio. (26%) 56 Mio. (23%)

MID-TERM TARGETS

  • › Target: operational cash flow to grow in line with EBITDA › op. cash flow > 75% of EBITDA
  • › Q1 2021: EUR 20.5 Mio. factoring reduced due to high liquidity and negative interest on bank accounts
  • › Inventory increased to cover chip shortage

INCREASE TRANSPARENCY ADDITIONAL DISCLOSURES 2021

IN TEUR EBIT ADJUSTMENTS
12,705 STATED EBIT
-312 Expenses stock options
-296 Restructuring
costs
Iskratel
-458 Restructuring costs North America
1,033 Change in accruals

settlement
AT tax
authorities
(see
next
slide)
-33 ONE TIME PROFIT EFFECTS
4,150 R&D Capitalization
-3,109 R&D Amortization
1,041 IMPACT R&D CAPITALIZATION
11,697 ADJUSTED EBIT
-2,554 PPA Amortization
14,251 ADJUSTED EBIT BEFORE PPA
IN TEUR OP. CASHFLOW ADJUSTMENTS
-26,805 STATED OP. CASHFLOW
20,616 Reduction in A/R factored from 31.12.2020 to 31.03.2021
754 Cash effect from one time profit effects
-5,435 ADJUSTED OP. CASHFLOW
ORGANIC GROWTH
in TEUR Q1-2020 Q1-2021
Stated revenue 270,079 294,093
M&A adjust Iskratel -16,879
M&A adjust Citycomp -9,948
M&A adjust HCS -1,427
M&A adjust KAD, MED 1,321
FX adjust +6,480
ORGANIC GROWTH 1.3%

INCREASE TRANSPARENCY ADDITIONAL DISCLOSURES 2021

ACCRUALS ANALYSIS
(in TEUR)
P&L impact 2019 2020 Q1-2021 Comment
TOTAL ACCRUALS no 84,348 67,319
Accruals
added
by
acquisitions
no 57,651
*
2,567 502 * EUR 54 Mio. Kapsch
Accruals used via P&L no -24,238
**
-21,600
**
-2,670 ** EUR 32 Mio. Kapsch
Accruals added via P&L yes 9,190 8,110 651
Accruals released via P&L yes -14,086 -2,202 -1,714
P&L impact by accrual changes 4,896 -5,908 1,063
RECURRING
REVENUES*
(in EUR Mio.)
2019 in % 2020 in % Q1-21 in %
Recurring
Revenues
288 25.6 344 27.4 101 34.3

* Stated Recurring revenues include Software, SLAs and maintenance (not Hardware sold with SLA, info to come 12/2021)

GEOGRAPHICAL SPLIT Q1-2021
(in %)
Revenue EBITDA
Europe 81.5% 95,1%
North America 7.4% -2.8%
Asia 6.5% 3.8%
RUS/BY/MD 4.6% 3.9%

ESG IMPROVEMENTS & GOALS – 2020,2021 AND BEYOND

COMMUTE & TRAVEL

Promotion of train travel, videoconferencing and Home-office work

PROMOTION OF CLEAN TECHNOLOGIES

Expansion of renewable energy usage, e.g. own photovoltaic systems

STEP-BY-STEP ESG PLAN

3 years plan to coordinate ESG topics on group level, clear target to improve ESG Ratings (MSCI to at least BB).

HUMAN DEVELOPMENT More Information on employee development programs

DIVERSITY

continue to increase share of women in S&T management positions from 21.6% up to 25.6% equaling the current gender distribution in S&T, new female SVB member

IMPROVED COMPLIANCE TRAINING SYSTEM

Group-wide online compliance training tool to be implemented in 2021

AUDIT COMMITTEE

increased audit committee independency since June 2020

STOCK OPTON PLAN & REMMUNERATION

New Stock Option Plan for broad employee base established, further initiatives to secure on fair and equal remuneration planned (including new targets/MTI)

ŝ ۰

COMMUNICATION

Intensify communication with "Kleinaktionären", e.g. new shareholder website was set up

Preparation
Scope
Reporting expansion
ESG-Goal extension
ESG-Risk assessment
Update Materiality
Analysis
I and II
Evaluation ESG-Goals
Implementation Stage II
Improved
reporting
according
to
recognised
ESG standards
Implementation Stage III
Finalization
Continuous
Improvement
Process
Stakeholder Dialog
Steps 2021 Steps 2022 Steps 2023

IT/IOT SERVICES

Target: improve EBITDA margin to > 10% (mix of IoT and service revenue)

* 3 rd Party revenue including intercompany revenue in Mio. EUR

** EBITDA before charged management fees from S&T AG (part of IT Services Segment); EBITDA after management fees: MEUR 12.3 (Q1-2021), MEUR 7.2 (Q1-2020)

*** HQ-fee adjusted EBITDA in % of external revenue

IOT SOLUTIONS EUROPE

"IoT Solutions Europe" will benefit a lot from 5G implementation in the next 3 years

  • * 3 rd Party revenue including intercompany revenue in Mio. EUR
  • ** EBITDA before charged management fees from S&T AG (part of IT Services Segment); EBITDA after management fees: MEUR 16.8 (Q1-2021), MEUR 15.7 (Q1-2020)
  • *** HQ-fee adjusted EBITDA in % of external revenue

IOT SOLUTIONS AMERICA

"IoT Solutions America" hit by chip crisis, USD development and Avionics

* 3 rd Party revenue including intercompany revenue in Mio. EUR

** EBITDA before charged management fees from S&T AG (part of IT Services Segment); EBITDA after management fees: MEUR -0.8 (Q1-2021), MEUR 2.1 (Q1-2020)

*** HQ-fee adjusted EBITDA in % of external revenue

SHAREHOLDER FOCUS TTS PROGRAM | TRUST – TRANSPARENCY - SHARE

TTS PROGRAM – REGAIN TRUST

  • › Investor Communities lost trust in S&T Management
  • › S&T always achieved or over-achieved its guidance since 2010
  • › While we almost doubled KPI´s since 2017, share price is flat
  • › Short Recommendation has raised concerns in respect to profitability and cash flow (addressed via PEC Program) and transparency
  • › With our TTS program, we want to
    • › Regain Trust
    • › Provide Transparency via Additional Disclosures
    • › Increase Dividends and SBP as part of Shareholder Focus

GUIDANCE TRACK RECORD (EBITDA FC VS ACT) (in EUR Mio.) 30.4 50 80 100 115 34.4 68.1 90.5 111.7 130.0 -5 15 35 55 75 95 115 135 2016 2017 2018 2019 2020

TRANSPARENCY | ADDITIONAL DISCLOSURES

  • › New Disclosures
  • › One-time effects on P&L
  • › One-time effects on cash flow
  • › Organic growth
  • › M&A impact on accruals
  • › Geographical exposure on Revenue/EBITDA
  • › Recurring Revenues
  • › Backlog by segments
  • › 442 investor meetings in 2020 117 in Q1/2021

SHAREHOLDER FOCUS TTS PROGRAM | DIVIDEND AND SHARE BUY BACKS

  • › Strategy: use 50% of net profits as dividend or share buybacks
  • › We propose a dividend of 30 Cent for 2020
  • › Why do we buy back shares ?
  • › Shares will be used as currency for M&A
  • › Currently S&T is valued at 10 times EBITDA, our M&A targets and peers are valued higher -> we limit buy backs at EUR 22,50
  • › EUR 400 Mio. available funds (cash, lines, own shares and cashflow)
  • › EUR 33 Mio. spent since 2019 EUR 10 Mio. new program starting May
DIVIDEND
& SHARE BUY
BACKS
2019 2020 2021 Comment
Dividend (cent) 16 30 Dividend for
FY 2020 = 1.4% of share price
Total Dividend (EUR Mio.) 10.6 19.5 2019 no dividend (to get Covid-19 subsidies)
Share Buy backs
(EUR Mio.)
14.6 20.3 21.0 2021: EUR 11 Mio. spend + new program
TOTAL SPENDINGS
(EUR Mio.)
25.2 20.3 40.5

BACKLOG & OPPORTUNITIES ORDERS AND DESIGN WINS REMAIN STRONG IN Q1 2021

2,7 02 0 500 1,000 1,500 2,000 2,500 3,000 Design wins 239 592 95 927 263 670 103 1,037 0 200 400 600 800 1,000 1,200 IT services IOT Europe IOT America Backlog 31.12.2020 31.03.2021 BACKLOG DEVELOPMENT REMAINS POSITIVE +11.8% + 17.0% +10.0% +8,4% +13.2%

RECENT DESIGN WINS COUNTRY VOLUME EUR
Medical respirator machines GER 62 Mio.
Public contracts PL 46 Mio.
Control for high-speed train CZ,LIT,DE,FR,UK 81 Mio.
AI for robots GER 25 Mio.
Medical surgical robots USA 20 Mio.
TOP CUSTOMERS 2020 COUNTRY VOLUME EUR
Medical respirator machines GER 33 Mio.
Social media compression system USA 25 Mio.
Global leader in medical equipment USA 22 Mio.
Control for high-speed train UK 25 Mio.
Avionics Entertainment System CN 16 Mio.
Top 10 customers account for 19% of Revenues, totally >3000 customers

Record order entry of EUR 404 Mio (Revenues EUR 294 Mio.) indicates strong further growth in FY2021

GUIDANCE 2021 CONTINUOUS GROWTH IN REVENUES, EBITDA AND EPS

Backlog EUR
Mio.
12/14 12/15 12/16 12/17 12/18 12/19 12/20
Project Pipeline 644 701 1,002 1,105 1,632 2,158 2,702
Scheduled Orders 157 181 306 474 841 841 927

CONTINUOUS GROSS MARGIN AND EBITDA MARGIN GROWTH

GM 33.0 % 33.9 % 33.5% 35.7 % 35.0% 36.3% 36.3% > 37%
EBITDA 5.9% 6.0% 6.8% 7.7% 9.1% 9.9% 10.4% >10%

Guidance 2021: min. EUR 1,400 Mio. Revenue – min. EUR 140 Mio. EBITDA – EPS 100 cent

SHORT AND MIDTERM GOALS | VISION 2030

GUIDANCE 2021 AGENDA 2023
Revenue: minimum EUR 1,400 Mio. 5 years plan 2018 2023p Growth
EBITDA: minimum EUR 140 Mio. Revenue 990 Mio. 2,000 Mio. +102%
EPS:
minimum 1 Euro
EBITDA 90.5 Mio. 220 Mio +143%
EPS 70 cent 175 cent +150%
VISION 2030
Digitalization SMART
Technologies
Transformation to
50% GM, 15% EBITDA
M&A
Strategy
Brand Awareness

Based on current forecasts and order backlog we confirm all short – mid and long-term plans

SUMMARY

ACHIEVEMENTS

  • › Revenue growth of 8.9% and EBITDA growth of 12.8%
  • › No economic impact due to Covid-19-Pandemic
  • › PEC Program is progressing well

TARGETS

  • › Guidance 2021:
  • › Revenue > EUR 1.4 Bn.
  • › EBITDA > EUR 140 Mio. and EPS ~ 1 EUR
  • › EUR 2 Bn. Revenues at > 11% EBITDA in 2023
  • › 2030: Transformation to IoT Service Player, EBITDA > 15%
  • › Ongoing Working Capital improvement
  • › MDAX membership

  • RISKS

  • › Chip shortage
  • › US-Dollar development
  • › Address right technology trends
  • › Attract sufficient engineers to support growth

OPPORTUNITIES

  • › Leading technologies in the growing IIoT market
  • › 5G connectivity for machines
  • › Growth areas America + China

  • › Q: Going into Q2, can you shed some light on how the semi shortage developed in April? Is it still a fact or do you see some improvements moving towards the end of Q2? How should we think of the phasing of the semi shortage?

  • › Q: Why are the inventories higher due to the chip shortage?

› Q: Does the strong order intake you showed in the first quarter include any double orders of customers who want to be on the safe side to receive their orders?

› Q: What was the order intake in Q1 2020?

  • › S&T: We would have expected to be over 300 million in Q1 without the shortage. Due to the chip shortage we could not ship EUR 10,5 Mio of requested customer in time. In Q2 we will pick up some of that . Semi shortage will not be zero after Q2, it still will be a problem, but I assume, S&T will be well over 600 million after Q2. We assume that the delinquency will reduce from 10 to 6 million in Q2. By the end of 2021 all problems should be solved.
  • › S&T: We face currently 62 chips on allocation. Out of those we could get hold of quantities on 43. Therefore we bought higher quantities of those to prepare for the future. (more than our regular 1 to 2 months approach). This increases the inventory. For the other chips on allocation we still fight to get them.
  • › S&T: There are no double orders. We had an order intake of 404 million and 294 million of revenues in Q1. From the difference of 110 million, we estimate roughly 30 million to be orders placed earlier than normal but no double orders. As you can see the pipeline is also strong. We had a lot of design wins recently and more and more of them are ramping up now. Our order intake is also progressing well in April and we expect a strong order intake throughout the full year.
  • › S&T: Around EUR 303 million in Q1 2020 (Q1 2021: EUR 404 Mio.).

› Q: On the project pipeline when I did the calculation correct, it has grown even more than the order intake. Could you share some information on this in terms of vertical markets?

› S&T: Yes, the pipeline was growing even more. The public sector does currently extremely well. Surprisingly even in the USA. A country that never touched railways, now has a significant budget under the Biden administration. We compete here for high speed trains in California, which is usually a typically European business. Governments like to spend money for infrastructure projects, and environmental programs, and programs that help them to transform their economy.

We also see industry coming back, with a lot of orders coming from smart factories and smart industrialization. Why coming back? The more robots you have in a factory, the less it is important how much you pay the worker per hour. It is the robot anyway who does the job and the robots cost the same everywhere. So apart from the costs which are similar, also for sustainably reasons, there is a trend of bringing production back.

Still strong is health and medical. We recently won a design win for surgical robots and there is a big trend to get data of all kind of medical systems centralized.

Markets that don't do well now are avionics – we don't see that picking up, and when we talk about industry – the "not so smart" industrial equipment, the not connected equipment. Like human machine interfaces for PLC's, which is a very traditional industrial equipment.

Last segment that is also doing well is e-mobility. S&T designs systems for several autonomous driving vehicles. S&T will never be a big player in the mass market but we see a niche in professional use. We just got a design win for autonomous mining machines.

› Q: Going into On the avionics business, to get a sense on how this should develop going forward – obviously the industry is still in a very though stage, on the other hand what we do see from airlines the procurement of new aircraft, which is more efficient, has not ended. The business that you have with upgrade vs. new aircraft delivery's how is that split and in general would you rather see given the Q1 development a steeper decline of the business or not necessarily?

› Q: On SusieTec. You mentioned additional revenue of EUR 250 million out of software licenses. Is that a figure that you expect for the near future?

› Q: The Iskratel revenue contribution in Q4 was 35 million but only 17 million in Q1 2021. Could you please clarify what is causing the seasonality in Iskratel revenues?

› S&T: The split between refurbished and new, we are serving both, and the split is probably 50:50 or a little bit more refurbished than new equipment. In Europe avionics currently is dead, in the US they slowly start to have more incountry flights again. On the other hand, the European industry is in a better shape because of subsidies, whereas the American is in much worse shape.

Currently we can get reasonable business only in China. China's in-country flights haven't been affected by any crises and we have good opportunities there. The forecast form avionics department is 18 million this year, we had less than 3 million in Q1.

  • › S&T: This year IOT Software revenue will end up around 55 million euro. Each license pulls some edge IOT devices with it, so to the license revenue you can add 3 times revenues of edge devices that we sell with the software. Our target by 2023 is to get the software license revenue up to 100 million. This will come with at least 250 million IOT devices.
  • › S&T: Iskratel has a lot of seasonality, also this year we are planning again, 35 million or more in Q4 2021. A lot of the Iskratel business is public business, which means it is planned and carried out according to the calendar year. At the end of the year the projects are finalized, you get paid and you can recognize the revenues. We are already working in Q1 on the revenues that we recognize at the end of the year. Midterm we expect that 5G IOT solutions will also attract more private business, which will reduce the seasonality.

  • › Q: On your plan to start a 4 th segment – from the current IT Services business, proximately which share of revenue will be shifted to the new segment IOT EE?

  • › Q: What is the reasoning why you don't just use the existing IT solutions Europe business, as the umbrella for the European operations? It might have been easier to form a single unit for the European market than to have 2 separate ones.
  • › Q: Is the profitability of the segments quite comparable or is there a significant difference? And is that's also true for the current operations?
  • › Q: On M&A given that we are in May and you target is 100 million, acquisition of additional revenues, how committed are you in any case to achieve this kind of target? Would you be potentially willing to pay higher prices? Do you push for achieving the revenue target at any price?

  • › S&T: We don't have the exact numbers yet but estimate 30-35% to be IoT business and 2/3 to be IT Services. However, the IoT part is growing faster, so by the time we implement the new segment split, it will be already a higher number than the estimated one.

  • › S&T: Main reason is that segments are formed on how they are controlled. Since different board members control operations in East and West Europe we opted for 2 segments. Second reason is transparency – to split into IT services and IoT is similar like in the past and therefore it's easier to compare the numbers.
  • › S&T: Yes, there is a difference, IOT can make more money than IT Services. Iskratel was just newly acquired so we have some work to do, but let's say in 2 years' time Iskratel will be for sure around 10 % EBITDA, IT services won't achieve that in 2 years.
  • › S&T: Internally we have very clear rules how we do acquisitions, for example we declared that we will not do acquisitions in problematic areas, like Russia. Another rule is that since S&T is valued at 10 times EBITDA, we will not buy companies more expansive than S&T. We will walk away from the deal if the price is not in a range where we expect it. This year we walked away from 3 to 4 deals already because they were too expensive. There will be always companies in financial troubles. Private equity cannot restructure them like us they have no synergies to raise. When prices are too high, we will not achieve 100 million this year but probably buy 200 million next year.

  • › Q: What was the M&A contribution in Q1?

  • › Q: Looking at Q1 2020 vs. Q1 2021 I would suspect, given the different phasing of Covid-19 and the respective effects allowed for some cost savings vs. Q1 20. Should we see it as a short-term effect that you had rather low operating expenses?
  • › Q: On CAPEX, the investments are higher than usually in the first quarter, what are the reasons?

› Q: How should we think about the decline of factoring? Do you have plans to exit from factoring as you obviously have some access cash?

  • › S&T: Around 26 million of revenue.
  • › S&T: We had 2020 quite a lot of subsidies in the range of 5.9 million. We will have additional cost savings, less travel cost, less office costs and so forth. It is a challenge to compensate the 2020 subsidies which we will not get in 2021 or at a much reduces level. You should expect even more cost reductions but less subsidies.
  • › S&T: 2 reasons for slightly higher CAPEX: 1) we completed some investments for the building in Germany that we acquired by the end of last year, and 2) we also pulled some investments earlier, in the year 2021. For example, in Austria the state is granting the so called "Investitionsprämie" on a twice high amount till end of May for investments into environmentally friendly energy production, etc.
  • › S&T: One of the big advantages of the factoring program is the flexibility. We can balance it according to our cash needs, and given the high liquidity position, and the lower flexibility of the banks, what concerns negative interest rates pass on, we decided to reduce the factoring amount for now. Depending on additional the cash needs, for example for M&A transactions, we can ramp it up anytime. Therefore factoring is attractive for us and stays as one of the financing strategies of S&T.

DISCLAIMER

This document includes 'forward-looking statements'. Forward-looking statements are all statements, which do not describe facts of the past, but containing the words "believe", "estimate", "expect", "anticipate", "assume", "plan", "intend", "could", and words of similar meaning. These forward-looking statements are subject to inherent risks and uncertainties since they relate to future events and are based on current assumptions and estimates of S&T AG, which might not occur at all or occur not as assumed. They therefore do not constitute a guarantee for the occurrence of future results or performances of S&T AG. The actual financial position and the actual results of S&T AG, as well as the overall economic development and the regulatory environment may differ materially from the expectations, which are assumed explicitly or implicitly in the forward-looking statements and do not comply to them. Analysts and investors, and any other person or entity that may need to take decisions or prepare or release opinions about the shares / securities issued by S&T AG are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date of this document. Past performance cannot be relied upon as a guide to future performance.

Except as required by applicable law, S&T AG undertakes no obligation to revise these forward-looking statements to reflect events and circumstances after the date of this presentation, including, without limitation, changes in S&T's business or strategy or to reflect the occurrence of unanticipated events. The financial information and opinions contained in this document are unaudited and are subject to change without notice. This document contains summarized information or information that has not been audited. In this sense, this information is subject to, and must be read in conjunction with, all other publicly available information, including if it is necessary, any fuller disclosure document published by S&T AG. None of the Company, its subsidiaries or affiliates or by any of its officers, directors, employees, advisors, representatives or agents shall be liable whatsoever for any loss however arising, directly or indirectly, from any use of this document its content or otherwise arising in connection with this document.

This document or any of the information contained herein do not constitute, form part of or shall be construed as an offer or invitation to purchase, subscribe, sale or exchange, nor a request for an offer of purchase, subscription, sale or exchange of shares / securities of S&T AG, or any advice or recommendation with respect to such shares / securities. This document or a part of it shall not form the basis of or relied upon in connection with any contract or commitment whatsoever.

This document does not constitute an offer to purchase securities in the United States, Canada, Australia, South Africa and Japan. Securities, including the bond of S&T AG may not be sold or offered for sale within the United States or to or for the account of / in favor of US citizens (as defined in Regulation S under the U.S. Securities Act of 1933 in the current version (the "Securities Act") unless they are registered under the regulations of the Securities Act or unless they are subject to an exemption from registration. Neither S&T AG nor any other person intend to register the offer or a part thereof in the United States or to make a public offer of the securities in the United States.

S&T AG

Industriezeile 35

A-4021 Linz

www.snt.at

IR Contact:

[email protected]

+43 (1) 80191 - 1196

Talk to a Data Expert

Have a question? We'll get back to you promptly.